Bath salts (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Bath salts" in English language version.

refsWebsite

Global rank English rank

8nih.gov

4^th place

4doi.org

2^nd place

2justice.gov

918^th place

556^th place

1archive.org

6^th place

1nihr.ac.uk

low place

6,693^rd place

1web.archive.org

1^st place

1cbc.ca

115^th place

82^nd place

1semanticscholar.org

11^th place

8^th place

archive.org

Jones, Marlene (2010). The Complete Guide to Creating Oils, Soaps, Creams, and Herbal Gels for Your Mind and Body: 101 Natural Body Care Recipes. Atlantic Publishing Company. ISBN 978-1601383693.

cbc.ca

Black, Matthew (25 June 2012). "What are 'bath salts'? A look at Canada's newest illegal drug". CBC News. Canadian Broadcasting Corporation. Retrieved 28 December 2013.

doi.org

Eczema in children: uncertainties addressed (Report). NIHR Evidence. 2024-03-19. doi:10.3310/nihrevidence_62438.
Santer M, Ridd MJ, Francis NA, Stuart B, Rumsby K, Chorozoglou M, Becque T, Roberts A, Liddiard L, Nollett C, Hooper J, Prude M, Wood W, Thomas KS, Thomas-Jones E, Williams HC, Little P (May 2018). "Emollient bath additives for the treatment of childhood eczema (BATHE): multicentre pragmatic parallel group randomised controlled trial of clinical and cost effectiveness". BMJ. 361: k1332. doi:10.1136/bmj.k1332. PMC 5930266. PMID 29724749.
Spiller HA, Ryan ML, Weston RG, Jansen J (2011). "Clinical experience with and analytical confirmation of "bath salts" and "legal highs" (synthetic cathinones) in the United States". Clinical Toxicology. 49 (6): 499–505. doi:10.3109/15563650.2011.590812. PMID 21824061. S2CID 33364692.
Coppola M, Mondola R (2012). "Synthetic cathinones: Chemistry, pharmacology and toxicology of a new class of designer drugs of abuse marketed as "bath salts" or "plant food"". Toxicology Letters. 211 (2): 144–149. doi:10.1016/j.toxlet.2012.03.009. PMID 22459606.

justice.gov

"DEA: Chemicals Used in "Bath Salts" Now Under Federal Control and Regulation". Archived from the original on 25 April 2014. Retrieved 28 December 2013.
"Situation Report. Synthetic Cathinones (Bath Salts): An Emerging Domestic Threat" (PDF). United States Department of Justice: National Drug Intelligence Center. Retrieved 1 June 2013.

nih.gov

pubmed.ncbi.nlm.nih.gov

Sukenik, S.; Neumann, L.; Buskila, D.; Kleiner-Baumgarten, A.; Zimlichman, S.; Horowitz, J. (1990). "Dead Sea bath salts for the treatment of rheumatoid arthritis". Clinical and Experimental Rheumatology. 8 (4): 353–357. PMID 2397624.
Sukenik, S.; Mayo, A.; Neumann, L.; Flusser, D.; Kleiner-Baumgarten, A.; Buskila, D. (1995). "Dead Sea bath salts for osteoarthritis of the knee". Harefuah. 129 (3–4): 100–103, 159, 103. PMID 8543232.
Evidence reviews for adding bath emollients to the management of atopic eczema in children under 12 years: Atopic eczema in under 12s: diagnosis and management: Evidence review A. NICE Evidence Reviews Collection. London: National Institute for Health and Care Excellence (NICE). 2023. ISBN 978-1-4731-5235-9. PMID 37616434.
Santer M, Ridd MJ, Francis NA, Stuart B, Rumsby K, Chorozoglou M, Becque T, Roberts A, Liddiard L, Nollett C, Hooper J, Prude M, Wood W, Thomas KS, Thomas-Jones E, Williams HC, Little P (May 2018). "Emollient bath additives for the treatment of childhood eczema (BATHE): multicentre pragmatic parallel group randomised controlled trial of clinical and cost effectiveness". BMJ. 361: k1332. doi:10.1136/bmj.k1332. PMC 5930266. PMID 29724749.
Spiller HA, Ryan ML, Weston RG, Jansen J (2011). "Clinical experience with and analytical confirmation of "bath salts" and "legal highs" (synthetic cathinones) in the United States". Clinical Toxicology. 49 (6): 499–505. doi:10.3109/15563650.2011.590812. PMID 21824061. S2CID 33364692.
Coppola M, Mondola R (2012). "Synthetic cathinones: Chemistry, pharmacology and toxicology of a new class of designer drugs of abuse marketed as "bath salts" or "plant food"". Toxicology Letters. 211 (2): 144–149. doi:10.1016/j.toxlet.2012.03.009. PMID 22459606.

ncbi.nlm.nih.gov

Evidence reviews for adding bath emollients to the management of atopic eczema in children under 12 years: Atopic eczema in under 12s: diagnosis and management: Evidence review A. NICE Evidence Reviews Collection. London: National Institute for Health and Care Excellence (NICE). 2023. ISBN 978-1-4731-5235-9. PMID 37616434.
Santer M, Ridd MJ, Francis NA, Stuart B, Rumsby K, Chorozoglou M, Becque T, Roberts A, Liddiard L, Nollett C, Hooper J, Prude M, Wood W, Thomas KS, Thomas-Jones E, Williams HC, Little P (May 2018). "Emollient bath additives for the treatment of childhood eczema (BATHE): multicentre pragmatic parallel group randomised controlled trial of clinical and cost effectiveness". BMJ. 361: k1332. doi:10.1136/bmj.k1332. PMC 5930266. PMID 29724749.

nihr.ac.uk

evidence.nihr.ac.uk

Eczema in children: uncertainties addressed (Report). NIHR Evidence. 2024-03-19. doi:10.3310/nihrevidence_62438.

semanticscholar.org

api.semanticscholar.org

Spiller HA, Ryan ML, Weston RG, Jansen J (2011). "Clinical experience with and analytical confirmation of "bath salts" and "legal highs" (synthetic cathinones) in the United States". Clinical Toxicology. 49 (6): 499–505. doi:10.3109/15563650.2011.590812. PMID 21824061. S2CID 33364692.

web.archive.org

"DEA: Chemicals Used in "Bath Salts" Now Under Federal Control and Regulation". Archived from the original on 25 April 2014. Retrieved 28 December 2013.